Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Berger, Allison"'
Autor:
Best S; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Liu T; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Bruss N; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Kittai A; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA., Berger A; Millennium Pharmaceuticals Inc., a wholly owned subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA, USA., Danilov AV; Knight Cancer Institute, Oregon Health and Science University, Portland, OR, USA.
Publikováno v:
Leukemia & lymphoma [Leuk Lymphoma] 2019 Dec; Vol. 60 (12), pp. 2946-2950. Date of Electronic Publication: 2019 May 21.
Autor:
Zhuang J; Department of Hematology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences, Beijing, China.; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Shirazi F; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Singh RK; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Kuiatse I; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Wang H; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Lee HC; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Berkova Z; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Berger A; Millennium Pharmaceuticals, Inc, a subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA; and., Hyer M; Millennium Pharmaceuticals, Inc, a subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA; and., Chattopadhyay N; Millennium Pharmaceuticals, Inc, a subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA; and., Syed S; Millennium Pharmaceuticals, Inc, a subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA; and., Shi JQ; Millennium Pharmaceuticals, Inc, a subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA; and., Yu J; Millennium Pharmaceuticals, Inc, a subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA; and., Shinde V; Millennium Pharmaceuticals, Inc, a subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA; and., Tirrell S; Millennium Pharmaceuticals, Inc, a subsidiary of Takeda Pharmaceutical Company Limited, Cambridge, MA; and., Jones RJ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Wang Z; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Davis RE; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX., Orlowski RZ; Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX.; Department of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
Blood [Blood] 2019 Apr 04; Vol. 133 (14), pp. 1572-1584. Date of Electronic Publication: 2019 Feb 08.
Autor:
Chattopadhyay N; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Berger AJ; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Koenig E; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Bannerman B; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Garnsey J; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Bernard H; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Hales P; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Maldonado Lopez A; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Yang Y; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Donelan J; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Jordan K; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Tirrell S; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Stringer B; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Xia C; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Hather G; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Galvin K; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Manfredi M; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America., Rhodes N; Metabolon Inc, Durham, North Carolina, United States of America., Amidon B; Takeda Pharmaceuticals International Co., Cambridge, Massachusetts, United States of America.
Publikováno v:
PloS one [PLoS One] 2015 Dec 28; Vol. 10 (12), pp. e0144825. Date of Electronic Publication: 2015 Dec 28 (Print Publication: 2015).
Autor:
Jazaeri AA; Corresponding Author: Amir A. Jazaeri, Division of Gynecologic Oncology, Department of Obstetrics & Gynecology, University of Virginia Health System, Box 800712, Charlottesville, VA 22908. aj2a@virginia.edu., Shibata E, Park J, Bryant JL, Conaway MR, Modesitt SC, Smith PG, Milhollen MA, Berger AJ, Dutta A
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2013 Oct; Vol. 12 (10), pp. 1958-67. Date of Electronic Publication: 2013 Aug 12.
Autor:
Nawrocki ST; Institute for Drug Development, Cancer Therapy and Research Center at The University of Texas Health Science Center at San Antonio, San Antonio, TX 78229, USA., Kelly KR, Smith PG, Espitia CM, Possemato A, Beausoleil SA, Milhollen M, Blakemore S, Thomas M, Berger A, Carew JS
Publikováno v:
Clinical cancer research : an official journal of the American Association for Cancer Research [Clin Cancer Res] 2013 Jul 01; Vol. 19 (13), pp. 3577-90. Date of Electronic Publication: 2013 Apr 30.